Visionary Holdings | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,103 results for “Visionary Holdings”

Trials

View all 99 →

A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple Sclerosis

55 participants · First posted Nov 13, 2020

VisionApp - Ghosting

12 participants · First posted May 6, 2026

VisionWay Accessibility

100 participants · First posted Jul 20, 2026

Drugs

View all 62 →

Pan-selectin antagonists (Visionary Pharmaceuticals)

DEP remdesivir (Starpharma Holdings)

Polyomavirus vaccine (BioE Holdings)

Organizations

View all 153 →

ARK INVESTMENTS (AUST) PTY LTD

Australia

Biglari Holdings

United States

BrightView Holdings

United States

News

View all 789 →

Visionary Holdings Partners with Yike Regenerative Medicine to Advance Anti-Aging Biotechnology

Visionary Holdings Launches Medical-Grade Stem Cell Anti-Aging Product Line in Asia

ERA 2025 to Feature Pivotal Nephrology Trials Including CONFIDENCE, ACHIEVE, and VISIONARY Studies

Page 1 of 111